Stay updated on EG-1962 vs Oral Nimodipine in Subarachnoid Hemorrhage Clinical Trial
Sign up to get notified when there's something new on the EG-1962 vs Oral Nimodipine in Subarachnoid Hemorrhage Clinical Trial page.

Latest updates to the EG-1962 vs Oral Nimodipine in Subarachnoid Hemorrhage Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has removed detailed information about a study comparing EG-1962 to standard treatment for aneurysmal subarachnoid hemorrhage, including inclusion and exclusion criteria, and the name of the study chair. A new revision number has been added.SummaryDifference6%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to EG-1962 vs Oral Nimodipine in Subarachnoid Hemorrhage Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EG-1962 vs Oral Nimodipine in Subarachnoid Hemorrhage Clinical Trial page.